CD8 T-Cell–Predominant Lymphocytic Esophagitis Associated with GERD
|
By LabMedica International staff writers Posted on 05 Oct 2021 |

Image: Histopathology photomicrograph of lymphocytic esophagitis: Esophageal mucosa showing peripapillary intraepithelial lymphocytosis with basal zone hyperplasia and intercellular edema. No significant population of eosinophils or neutrophils is identified (Photo courtesy of Yusuf Kasirye, MD, et al)
In patients with reflux esophagitis (RE), increased lymphocytes are often part of a mixed inflammatory infiltrate that also includes eosinophils and/or neutrophils. Less frequently, lymphocytes are the only type of inflammatory cells associated with gastroesophageal reflux disease (GERD).
One such pattern is lymphocytic esophagitis (LyE), which is characterized by an elevated number of peripapillary lymphocytes and absent or rare intraepithelial granulocytes. This pattern has been reported in approximately 5% of patients with endoscopic esophagitis and 7% of patients with Barrett esophagus.
Clinical Scientists at the Dartmouth-Hitchcock Medical Center (Lebanon, NH, USA) conducted an observational retrospective study and identified 161 patients seen at their institution from 1998 to 2014 who were diagnosed with GERD, had normal esophageal motility, and available esophageal biopsies. For all patients meeting inclusion criteria, the team obtained demographic data as well as information pertaining to clinical diagnosis, past medical history, and endoscopic, imaging, manometry, and, where available, pH-metry findings from the files and electronic medical records.
Biopsy specimens were fixed in 10% formalin, paraffin-embedded, and stained with hematoxylin-eosin. A single peripapillary lymphoid infiltrate was sufficient for the diagnosis of LyE. The cutoffs for a normal number of intraepithelial lymphocytes evaluated in hematoxylin-eosin–stained slides at different levels, such as gastroesophageal junction, distal esophagus, and midesophagus were 62, 46, and 41 lymphocytes per high-power field, respectively. Cells were counted in one mostly affected high-power field using an Olympus BX 41 microscope (Olympus, Center Valley, PA, USA). Routine CD4 and CD8 immunohistochemistry was performed using Bond Polymer Refine Detection staining reagents and Bond III autostainer (Leica Microsystems, Buffalo Grove, IL, USA).
The scientists found increased intraepithelial lymphocytes in 13.7% of patients with GERD. Two major patterns and one minor pattern of lymphocytic inflammation were observed as follows: (1) LyE (in 6.8% [11 of 161] of patients and typically focal), (2) dispersed lymphocytes in an area of reflux esophagitis (in 5.6% [9 of 161] and typically diffuse), and (3) peripapillary lymphocytes in an area of reflux esophagitis (in 1.2% [2 of 161]). CD8 T cells significantly outnumbered CD4 T cells in 91% of patients with lymphocytic esophagitis and 100% of patients with dispersed lymphocytes (9 of 9) or peripapillary lymphocytes (2 of 2) in the area of reflux esophagitis.
The authors concluded that their findings suggest that LyE is one of the major patterns of lymphocytic inflammation in GERD. CD8 T-cell–predominant immunophenotype may be useful as a marker of GERD in the differential diagnosis of LyE. The study was published in the September 2021 issue of the journal Archives of Pathology and Laboratory Medicine.
Related Links:
Dartmouth-Hitchcock Medical Center
Olympus
Leica Microsystems
One such pattern is lymphocytic esophagitis (LyE), which is characterized by an elevated number of peripapillary lymphocytes and absent or rare intraepithelial granulocytes. This pattern has been reported in approximately 5% of patients with endoscopic esophagitis and 7% of patients with Barrett esophagus.
Clinical Scientists at the Dartmouth-Hitchcock Medical Center (Lebanon, NH, USA) conducted an observational retrospective study and identified 161 patients seen at their institution from 1998 to 2014 who were diagnosed with GERD, had normal esophageal motility, and available esophageal biopsies. For all patients meeting inclusion criteria, the team obtained demographic data as well as information pertaining to clinical diagnosis, past medical history, and endoscopic, imaging, manometry, and, where available, pH-metry findings from the files and electronic medical records.
Biopsy specimens were fixed in 10% formalin, paraffin-embedded, and stained with hematoxylin-eosin. A single peripapillary lymphoid infiltrate was sufficient for the diagnosis of LyE. The cutoffs for a normal number of intraepithelial lymphocytes evaluated in hematoxylin-eosin–stained slides at different levels, such as gastroesophageal junction, distal esophagus, and midesophagus were 62, 46, and 41 lymphocytes per high-power field, respectively. Cells were counted in one mostly affected high-power field using an Olympus BX 41 microscope (Olympus, Center Valley, PA, USA). Routine CD4 and CD8 immunohistochemistry was performed using Bond Polymer Refine Detection staining reagents and Bond III autostainer (Leica Microsystems, Buffalo Grove, IL, USA).
The scientists found increased intraepithelial lymphocytes in 13.7% of patients with GERD. Two major patterns and one minor pattern of lymphocytic inflammation were observed as follows: (1) LyE (in 6.8% [11 of 161] of patients and typically focal), (2) dispersed lymphocytes in an area of reflux esophagitis (in 5.6% [9 of 161] and typically diffuse), and (3) peripapillary lymphocytes in an area of reflux esophagitis (in 1.2% [2 of 161]). CD8 T cells significantly outnumbered CD4 T cells in 91% of patients with lymphocytic esophagitis and 100% of patients with dispersed lymphocytes (9 of 9) or peripapillary lymphocytes (2 of 2) in the area of reflux esophagitis.
The authors concluded that their findings suggest that LyE is one of the major patterns of lymphocytic inflammation in GERD. CD8 T-cell–predominant immunophenotype may be useful as a marker of GERD in the differential diagnosis of LyE. The study was published in the September 2021 issue of the journal Archives of Pathology and Laboratory Medicine.
Related Links:
Dartmouth-Hitchcock Medical Center
Olympus
Leica Microsystems
Latest Pathology News
- Genetics and AI Improve Diagnosis of Aortic Stenosis
- AI Tool Simultaneously Identifies Genetic Mutations and Disease Type
- Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups
- Tumor Signals in Saliva and Blood Enable Non-Invasive Monitoring of Head and Neck Cancer
- Common Health Issues Can Influence New Blood Tests for Alzheimer’s Disease
- Blood Test Formula Identifies Chronic Liver Disease Patients with Higher Cancer Risk
- Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
- AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
- AI Tool Rapidly Analyzes Complex Cancer Images for Personalized Treatment
- Diagnostic Technology Performs Rapid Biofluid Analysis Using Single Droplet
- Novel Technology Tracks Hidden Cancer Cells Faster
- AI Tool Improves Breast Cancer Detection
- AI Tool Predicts Treatment Success in Rectal Cancer Patients
- Blood Test and Sputum Analysis Predict Acute COPD Exacerbation
- AI Tool to Transform Skin Cancer Detection with Near-Perfect Accuracy
- Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis
Channels
Clinical Chemistry
view channel
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more
Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
People with diabetes often need to measure their blood glucose multiple times a day, most commonly through finger-prick blood tests or implanted sensors. These methods can be painful, inconvenient, and... Read moreMolecular Diagnostics
view channel
Urine Test Could Reveal Real Age and Life Span
Chronological age does not always reflect how quickly the body is aging, as biological age is shaped by genetics, stress, sleep, nutrition, and lifestyle factors such as smoking. A higher biological age... Read more
Genomic Test Identifies African Americans at Risk for Early Prostate Cancer Recurrence
Prostate cancer is one of the most commonly diagnosed cancers in men and a leading cause of cancer-related death, particularly in the United States. African American men face a disproportionately higher... Read moreHematology
view channel
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
Colon cancer remains a major cause of cancer-related illness, with many patients facing relapse even after surgery and chemotherapy. Up to 40% of people with stage III disease experience recurrence, highlighting... Read moreMicrobiology
view channel
New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
Urinary tract infections affect around 152 million people every year, making them one of the most common bacterial infections worldwide. In routine medical practice, diagnosis often relies on rapid urine... Read more
Breakthroughs in Microbial Analysis to Enhance Disease Prediction
Microorganisms shape human health, ecosystems, and the planet’s climate, yet identifying them and understanding how they are related remains a major scientific challenge. Even with modern DNA sequencing,... Read moreTechnology
view channel
AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
Colorectal cancer is one of the most common and deadly cancers worldwide, and accurately predicting patient survival remains a major clinical challenge. Traditional prognostic tools often rely on either... Read more
Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
Glioblastoma is one of the most aggressive and fatal brain cancers, with most patients surviving less than two years after diagnosis. Treatment is particularly challenging because the tumor infiltrates... Read moreIndustry
view channel
BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has entered into a strategic collaboration with the Institute for Immunology and Immune Health (I3H, Philadelphia, PA, USA) at the University... Read more




 assay.jpg)


 Analyzer.jpg)